Remicade (infliximab) for the treatment of Crohn's disease

被引：0
|
作者：
Brazier, F [1 ]
Delcenserie, R [1 ]
Dupas, JL [1 ]
机构：
[1] CHU Nord, Serv Hepatogastroenterol, F-80054 Amiens, France
来源：
PRESSE MEDICALE | 2000年 / 29卷 / 26期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1463 / 1464
页数：2
相关论文
共 50 条
  • [21] Treatment of pulmonary Crohn's disease with infliximab
    See, MC
    Venkataraman, P
    Newman, LJ
    Berezin, SH
    Medow, CM
    Halata, MS
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S296 - S296
  • [22] Treatment of oesophageal Crohn's disease by infliximab
    Filippi, J
    Mambrini, P
    Arab, K
    Schneider, SM
    Hébuterne, X
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (01): : 84 - 85
  • [23] Treatment of oesophageal Crohn's disease with infliximab
    Theodoropoulou, A
    Koutroubakis, LE
    Kouroumalis, EA
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (04) : 431 - 432
  • [24] Treatment of fistulas in Crohn's disease with infliximab
    Löfberg, R
    GUT, 1999, 45 (05) : 642 - 643
  • [25] Comparison of remicade to curcumin for the treatment of Crohn's disease: A systematic review
    Schneider, Allaire
    Hossain, Ivy
    VanderMolen, Julia
    Nicol, Kara
    COMPLEMENTARY THERAPIES IN MEDICINE, 2017, 33 : 32 - 38
  • [26] Quantitative benefit-risk modelling of infliximab biosimilar inflectra versus reference product remicade in the treatment of Crohn's disease
    Catt, Heather
    Hughes, Dyfrig
    Bodger, Keith
    Kirkham, Jamie
    TRIALS, 2017, 18
  • [27] Risks and benefits of infliximab for the treatment of Crohn's disease
    Siegel, Corey A.
    Hur, Chin
    Korzenik, Joshua R.
    Sands, Bruce E.
    GASTROENTEROLOGY, 2006, 130 (04) : A71 - A72
  • [28] Early treatment with infliximab for Crohn's disease patients
    de Chambrun, G. Pineton
    Libier, L.
    Nachury, M.
    Collins, M.
    Koriche, D.
    Gower-Rousseau, C.
    Zerbib, P.
    Cortot, A.
    Colombel, J. -F.
    Desreumaux, P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S251 - S252
  • [29] Recent Trends of Infliximab Treatment for Crohn's Disease
    Kim, Mi Jin
    Choe, Yon Ho
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2012, 15 (01) : 19 - 22
  • [30] Infliximab in the treatment of refractory gastroduodenal Crohn's disease
    del Carmen Rodriguez-Grau, Maria
    Chaparro, Maria
    Diaz, Raquel
    Gisbert, Javier R.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2014, 37 (01): : 21 - 22
12345